摘要
目的:探讨酮咯酸氨丁三醇注射液联合亚甲蓝用于肛肠疾病术后镇痛的临床价值。方法:将2019年5月至2020年5月,本院接受外科手术治疗的88例肛肠疾病患者,根据手术时间的先后顺序分为观察组与对照组各44例。观察组术后采用酮咯酸氨丁三醇注射液联合亚甲蓝镇痛治疗,对照组术后仅采用酮咯酸氨丁三醇注射液镇痛。对比2组患者疼痛持续时间、镇痛效果及不良反应发生率。结果:观察组疼痛持续时间短于对照组(P<0.05),镇痛效果优于对照组(P<0.05)。观察组患者不良反应发生率为22.73%,低于对照组的45.45%,差异有统计学意义(P<0.05)。结论:肛肠疾病术后应用酮咯酸氨丁三醇注射液联合亚甲蓝镇痛,可在短时间内发挥较好的镇痛效果,且不良反应发生率较低,在促进患者康复的同时,还能为其提供较好的安全保障。
Objective To explore the clinical value of postoperative analgesia of ketorolac tromethamine(KT)injection plus methylene blue(MB)on coloproctological disease patients.MI ethodsAccording to the time sequencies of patients receiving surgery divided 88 cases met above conditions in author's hospital(2019-05-2020-05)into observation group(44 cases,adopted KT plus MB for analgesia)and control group(44 cases,alone KT injection for doing so);then,compared both groups pain lasting time,analgetic efficacy,and the incidence of unward reaction.Results In pain lasting time,in the incidence of unward reactions,and in analgetic efficacy,observation group was respectively shorter,lower(22.73%vs 45.45%)than,and superior to control group(all,P<o.05).Conclusion After surgery for coloproctological diseases adopting KT injection plus MB for analgesia can play better analgetic efficacy in shorter time,and only with lower incidence of unward reactions,meanwhile,promote patients rehabilitation,and provide them safety ensure.
作者
王海成
WANG Hai-cheng(Coloproctological Dept.,Heze City's Hospital of TCM,Heze,Shandong 274000)
出处
《中国肛肠病杂志》
2023年第6期47-49,共3页
Chinese Journal of Coloproctology
关键词
肛肠疾病
酮咯酸氨丁三醇注射液
亚甲蓝
镇痛
Coloproctological disease
Ketorolac tromethamine
Methylene blue
Analgesia